Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Central Nervous System Neoplasms 5Glioblastoma 4Brain Neoplasms 3Astrocytoma 3Lymphoma 2Glioma 2Spinal Cord Neoplasms 1Recurrence 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Large-Cell, Anaplastic 1Gliosarcoma 1

Interventions

Cyclophosphamide 5Vincristine 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Doxorubicin 3Cyclosporine 3Antilymphocyte Serum 3fludarabine phosphate 2Psychiatric Rehabilitation 2Mycophenolic Acid 2Melphalan 2Gemcitabine 2Flow Cytometry 2Cytarabine 2Cisplatin 2Carboplatin 2Busulfan 2Alemtuzumab 2sargramostim 1romidepsin 1motesanib diphosphate 1lorlatinib 1etoposide phosphate 1carbendazim 1Whole-Body Irradiation 1Vindesine 1Vinblastine 1Thiotepa 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large-Cell, Anaplastic × Lomustine × Clear all
NCT00317408 2015-09-25

Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase NA Unknown
96 enrolled
Lymphoid

Lymphoma, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡